tradingkey.logo
搜索

Sonoma Pharmaceuticals Inc

SNOA
添加自选
1.210USD
0.0000.00%
收盘 07/02, 13:00美东报价延迟15分钟
2.09M总市值
亏损市盈率 TTM

关于 Sonoma Pharmaceuticals Inc 公司

Sonoma Pharmaceuticals, Inc. is a global healthcare company. The Company is engaged in developing and producing stabilized hypochlorous acid (HOCl) products for a range of applications, including wound care, eye care, nasal care, oral care, dermatological conditions, podiatry, animal health care and non-toxic disinfectants. Its products are all classified as medical devices and categorized as prescription, over-the-counter (OTC) and office dispense products. It offers both prescription and OTC dermatology products, including Epicyn Facial Cleanser, Levicyn Dermal Spray, Levicyn Gel, Levicyn Spray Gel, Celacyn Scar Management Gel. In the United States, it offers Microcyn wound and skin care both as an OTC and prescription product. Its eyecare products include Acuiycn Eyelid and Eyelash Hygiene, and Ocucyn Eyelid and Eyelash Cleanser. MicrocynAH is an HOCl-based topical product that cleans, debrides and treats a wide spectrum of animal wounds and infections.

Sonoma Pharmaceuticals Inc简介

公司代码SNOA
公司名称Sonoma Pharmaceuticals Inc
上市日期Jan 26, 2007
CEOTrombly (Amy)
员工数量168
证券类型Ordinary Share
年结日Jan 26
公司地址5445 Conestoga Court, Suite 150
城市BOULDER
上市交易所NASDAQ OMX - NASDAQ BASIC
国家United States of America
邮编80301
电话18007599305
网址https://sonomapharma.com/
公司代码SNOA
上市日期Jan 26, 2007
CEOTrombly (Amy)

Sonoma Pharmaceuticals Inc公司高管

名称
名称/职务
职务
持股
持股变动
Dr. Jay E. Birnbaum, Ph.D.
Dr. Jay E. Birnbaum, Ph.D.
Independent Director
Independent Director
286.00
-0.35%
Mr. Jerry G. Mclaughlin
Mr. Jerry G. Mclaughlin
Lead Independent Director
Lead Independent Director
--
--
Mr. Philippe Weigerstorfer
Mr. Philippe Weigerstorfer
Independent Director
Independent Director
--
--
Ms. Amy Trombly
Ms. Amy Trombly
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Jerry Dvonch
Mr. Jerry Dvonch
Chief Financial Officer
Chief Financial Officer
--
--
名称
名称/职务
职务
持股
持股变动
Dr. Jay E. Birnbaum, Ph.D.
Dr. Jay E. Birnbaum, Ph.D.
Independent Director
Independent Director
286.00
-0.35%
Mr. Jerry G. Mclaughlin
Mr. Jerry G. Mclaughlin
Lead Independent Director
Lead Independent Director
--
--
Mr. Philippe Weigerstorfer
Mr. Philippe Weigerstorfer
Independent Director
Independent Director
--
--
Ms. Amy Trombly
Ms. Amy Trombly
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Jerry Dvonch
Mr. Jerry Dvonch
Chief Financial Officer
Chief Financial Officer
--
--

常见问题

Sonoma Pharmaceuticals Inc的前五大股东是谁?

Sonoma Pharmaceuticals Inc 的前五大股东如下:Dr. Jay E. Birnbaum, Ph.D.

有多少机构持有Sonoma Pharmaceuticals Inc(SNOA)的股份?

截至2026Q1,共有40家机构持有Sonoma Pharmaceuticals Inc的股份,合计持有的股份价值约为127.80K,占公司总股份的3.68%。与2025Q4相比,机构持股有所增加,增幅为-34692.00。

哪个业务部门对Sonoma Pharmaceuticals Inc的收入贡献最大?

在2026Q1,Human Care业务部门对Sonoma Pharmaceuticals Inc的收入贡献最大,创收3.86M,占总收入的88.83%。